In response to the Coronavirus (COVID-19) pandemic, IgM/IgG antibody rapid test kit to equip healthcare workers for rapid COVID-19 antibody detection. This COVID-19 Rapid Test Kit is suitable for the qualitative detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. Common signs of infection with SARS-CoV-2 include respiratory symptoms, fever, cough, shortness of breath, and dyspnea. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death. SARS-CoV-2 can be excreted through respiratory secretions or transmitted through oral fluids, sneezing, physical contact, and through air droplets.
This report contains market size and forecasts of COVID-19 Antibody Rapid Test Kits in global, including the following market information:
Global COVID-19 Antibody Rapid Test Kits Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global COVID-19 Antibody Rapid Test Kits Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five COVID-19 Antibody Rapid Test Kits companies in 2021 (%)
The global COVID-19 Antibody Rapid Test Kits market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
IgG Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of COVID-19 Antibody Rapid Test Kits include RayBiotech Life, Aurora Biomed, SD Biosensor, Abingdon Health, INSTI, CTK Biotech, SBL Testing Technologies, Biopanda and Roche Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the COVID-19 Antibody Rapid Test Kits manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global COVID-19 Antibody Rapid Test Kits Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global COVID-19 Antibody Rapid Test Kits Market Segment Percentages, by Type, 2021 (%)
IgG Test
IgM Test
Others
Global COVID-19 Antibody Rapid Test Kits Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global COVID-19 Antibody Rapid Test Kits Market Segment Percentages, by Application, 2021 (%)
Hospital
Company
School
Home
Others
Global COVID-19 Antibody Rapid Test Kits Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global COVID-19 Antibody Rapid Test Kits Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies COVID-19 Antibody Rapid Test Kits revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies COVID-19 Antibody Rapid Test Kits revenues share in global market, 2021 (%)
Key companies COVID-19 Antibody Rapid Test Kits sales in global market, 2017-2022 (Estimated), (K Units)
Key companies COVID-19 Antibody Rapid Test Kits sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
RayBiotech Life
Aurora Biomed
SD Biosensor
Abingdon Health
INSTI
CTK Biotech
SBL Testing Technologies
Biopanda
Roche Diagnostics
TestLine Clinical Diagnostics
Assay Genie
Nadal-test
Panodyne
Luminex